This confirmed previous findings where CD2/CD18 co-expression was reduced in the same CD56dimCD16− NK cell phenotype in a cohort of moderate CFS/ME patients [24]. This evidence concerns the gene ITGB2 and myalgic encephalomeyelitis/chronic fatigue syndrome.